Sudden cardiac death MRI: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(/* 2022 ESC Guidelines for the management of patients with ventricular arrythymias and the prevention of sudden cardiac death {{cite journal| author=Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA | display-authors=etal| title=2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. | journal=Eur Heart J | year= 2022 | volume= 43 | issue= 40 | pages= 3997-4126 | pmid=36017572 | doi=10.1093/eurheartj/ehac26...)
 
(11 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Sudden cardiac death}}
{{Sudden cardiac death}}
{{CMG}} {{AE}} {{Sara.Zand}}
{{CMG}} {{AE}} {{Sara.Zand}} {{EdzelCo}}


==Overview==
==Overview==


[[Cardiac MRI]] is an accurate modality for diagnosis of structural and functional causes of [[cardiac arrest]] by the evaluation of  
[[Cardiac]] [[magnetic resonance imaging]] ([[MRI]]) is an accurate modality for [[diagnosis]] of structural and functional causes of [[cardiac arrest]] by the evaluation of [[chamber volumes]], [[left ventricular]] and [[right ventricular]] mass, size and function, and [[regional wall motion abnormality]].
[[chamber volumes]],[[left ventricular]] mass
, [[left ventricular]] size and function
,[[ right ventricular]] size and [[function]]
,[[regional wall motion abnormality]]


===MRI===
==MRI==


[[Cardiac MRI]] is an accurate modality for diagnosis of structural and functional causes of [[cardiac arrest]] by the evaluation of the following:<ref name="ZarebaZareba2017">{{cite journal|last1=Zareba|first1=Wojciech|last2=Zareba|first2=Karolina M.|title=Cardiac Magnetic Resonance in Sudden Cardiac Arrest Survivors|journal=Circulation: Cardiovascular Imaging|volume=10|issue=12|year=2017|issn=1941-9651|doi=10.1161/CIRCIMAGING.117.007290}}</ref>
*[[Cardiac]] [[magnetic resonance imaging]] ([[MRI]]) is an accurate modality for [[diagnosis]] of structural and functional causes of [[cardiac arrest]] by the evaluation of [[chamber volumes]], [[left ventricular]] and [[right ventricular]] mass, size and function, and [[regional wall motion abnormality]]. <ref name="ZarebaZareba2017">{{cite journal|last1=Zareba|first1=Wojciech|last2=Zareba|first2=Karolina M.|title=Cardiac Magnetic Resonance in Sudden Cardiac Arrest Survivors|journal=Circulation: Cardiovascular Imaging|volume=10|issue=12|year=2017|issn=1941-9651|doi=10.1161/CIRCIMAGING.117.007290}}</ref>
* This imaging identifies presence of [[myocardial edema]], [[infiltration]], [[fibrosis]], and [[perfusion defects]].


* [[Chamber volumes]]
 
* [[Left ventricular]] mass
==2022 ESC Guidelines for the management of patients with ventricular arrythymias and the prevention of sudden cardiac death <ref name="pmid36017572">{{cite journal| author=Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA | display-authors=etal| title=2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. | journal=Eur Heart J | year= 2022 | volume= 43 | issue= 40 | pages= 3997-4126 | pmid=36017572 | doi=10.1093/eurheartj/ehac262 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=36017572  }} </ref>==
* [[Left ventricular]] size, function
 
* [[ Right ventricular]] size and [[function]]
{|class="wikitable"
* [[Regional wall motion abnormality]]
|-
| colspan="1" style="text-align:center; background: Silver"|'''Recommendations for evaluation of patients presenting with newly documented ventricular arryhthmia'''''
|-
| colspan="1" style="text-align:center; background:LemonChiffon"|'''[[2022 ESC Guidelines Classification Scheme#Classification of Recommendations|Class IIa]] ''([[2022 ESC Guidelines Classification Scheme#Level of Evidence|Level of Evidence: C]])'''''
|-
| bgcolor="LemonChiffon"|
* In [[patients]] with newly documented [[ventricular arrhythmia]] ([[VA]]) (frequent [[premature ventricular contractions]] ([[PVCs]]), [[non-sustained ventricular tachycardia]] ([[NSVT]])and suspicion of [[structural heart disease]] ([[SHD]]) other than [[coronary artery disease]] ([[CAD]]) after initial evaluation, a [[cardiac magnetic resonance]] ([[CMR]]) should be considered.
|}
 
{|class="wikitable"
|-
| colspan="1" style="text-align:center; background: Silver"|'''Recommendations for evaluation of sudden cardiac arrest survivors'''''
|-
| colspan="1" style="text-align:center; background:LightGreen"|'''[[2022 ESC Guidelines Classification Scheme#Classification of Recommendations|Class I]] ''([[2022 ESC Guidelines Classification Scheme#Level of Evidence|Level of Evidence: B]])'''''
|-
| bgcolor="LightGreen"|
* [[Coronary imaging]] and [[CMR]] with [[late gadolinium enhancement]] ([[LGE]]) are recommended for evaluation of [[cardiac structure]] and [[function]] in all [[SCA]] survivors without a clear underlying cause.
|}
 
{|class="wikitable"
|-
| colspan="1" style="text-align:center; background: Silver"|'''Recommendations for the management of patients with premature ventricular complex-induced or premature ventricular complex-aggravated cardiomyopathy'''''
|-
| colspan="1" style="text-align:center; background:LemonChiffon"|'''[[2022 ESC Guidelines Classification Scheme#Classification of Recommendations|Class IIa]] ''([[2022 ESC Guidelines Classification Scheme#Level of Evidence|Level of Evidence: C]])'''''
|-
| bgcolor="LemonChiffon"|
* In [[patients]] with suspected [[premature ventricular complex]] ([[PVC]])-induced [[cardiomyopathy]], [[cardiac magnetic resonance]] ([[CMR]]) should be considered.
|}
 
{|class="wikitable"
|-
| colspan="1" style="text-align:center; background: Silver"|'''Recommendations for evaluation of patients presenting with dilated cardiomyopathy/ hypokinetic non-dilated cardiomyopathy'''''
|-
| colspan="1" style="text-align:center; background:LemonChiffon"|'''[[2022 ESC Guidelines Classification Scheme#Classification of Recommendations|Class IIa]] ''([[2022 ESC Guidelines Classification Scheme#Level of Evidence|Level of Evidence: B]])'''''
|-
| bgcolor="LemonChiffon"|
* [[CMR]] with [[LGE]] should be considered in [[dilated cardiomyopathy]] ([[DCM]])/[[hypokinetic non-dilated cardiomyopathy]] ([[HNDCM]]) [[patients]] for assessing the [[etiology]] and the [[risk]] of [[ventricular arryhthmia]] ([[VA]])/ [[sudden cardiac death]] ([[SCD]]).
|}
 
{|class="wikitable"
|-
| colspan="1" style="text-align:center; background: Silver"|'''Recommendations for diagnosis of ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy'''''
|-
| colspan="1" style="text-align:center; background:LightGreen"|'''[[2022 ESC Guidelines Classification Scheme#Classification of Recommendations|Class I]] ''([[2022 ESC Guidelines Classification Scheme#Level of Evidence|Level of Evidence: B]])'''''
|-
| bgcolor="LightGreen"|
* In [[patients]] with suspected [[arrhythmogenic right ventricular cardiomyopathy]] ([[ARVC]]), [[CMR]] is recommended.
|}
 
{|class="wikitable"
|-
| colspan="1" style="text-align:center; background: Silver"|'''Recommendations for diagnosis of ventricular arrhythmias in hypertrophic cardiomyopathy'''''
|-
| colspan="1" style="text-align:center; background:LightGreen"|'''[[2022 ESC Guidelines Classification Scheme#Classification of Recommendations|Class I]] ''([[2022 ESC Guidelines Classification Scheme#Level of Evidence|Level of Evidence: B]])'''''
|-
| bgcolor="LightGreen"|
* [[CMR]] with [[LGE]] is recommended in [[HCM]] patients for [[diagnostic workup]].
|}


==2017AHA/ACC/HRS Guideline for management of [[sudden cardiac arrest]] and [[ventricular arrhythmia]]==
==2017AHA/ACC/HRS Guideline for management of [[sudden cardiac arrest]] and [[ventricular arrhythmia]]==
<ref name="Al-KhatibStevenson2018">{{cite journal|last1=Al-Khatib|first1=Sana M.|last2=Stevenson|first2=William G.|last3=Ackerman|first3=Michael J.|last4=Bryant|first4=William J.|last5=Callans|first5=David J.|last6=Curtis|first6=Anne B.|last7=Deal|first7=Barbara J.|last8=Dickfeld|first8=Timm|last9=Field|first9=Michael E.|last10=Fonarow|first10=Gregg C.|last11=Gillis|first11=Anne M.|last12=Granger|first12=Christopher B.|last13=Hammill|first13=Stephen C.|last14=Hlatky|first14=Mark A.|last15=Joglar|first15=José A.|last16=Kay|first16=G. Neal|last17=Matlock|first17=Daniel D.|last18=Myerburg|first18=Robert J.|last19=Page|first19=Richard L.|title=2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death|journal=Circulation|volume=138|issue=13|year=2018|issn=0009-7322|doi=10.1161/CIR.0000000000000549}}</ref>
{|class="wikitable"
{|class="wikitable"
|-
|-

Latest revision as of 18:13, 22 July 2023

Sudden cardiac death Microchapters

Home

Patient Information

Sudden Cardiac versus Non-Cardiac Death

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Definitions and Diagnosis

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Urgent Treatment

Post Arrest Care and Prevention

Ethical Issues

Sudden cardiac death MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sudden cardiac death MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sudden cardiac death MRI

CDC on Sudden cardiac death MRI

Sudden cardiac death MRI in the news

Blogs on Sudden cardiac death MRI

Directions to Hospitals Treating Sudden cardiac death

Risk calculators and risk factors for Sudden cardiac death MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Edzel Lorraine Co, DMD, MD[3]

Overview

Cardiac magnetic resonance imaging (MRI) is an accurate modality for diagnosis of structural and functional causes of cardiac arrest by the evaluation of chamber volumes, left ventricular and right ventricular mass, size and function, and regional wall motion abnormality.

MRI


2022 ESC Guidelines for the management of patients with ventricular arrythymias and the prevention of sudden cardiac death [2]

Recommendations for evaluation of patients presenting with newly documented ventricular arryhthmia
Class IIa (Level of Evidence: C)
Recommendations for evaluation of sudden cardiac arrest survivors
Class I (Level of Evidence: B)
Recommendations for the management of patients with premature ventricular complex-induced or premature ventricular complex-aggravated cardiomyopathy
Class IIa (Level of Evidence: C)
Recommendations for evaluation of patients presenting with dilated cardiomyopathy/ hypokinetic non-dilated cardiomyopathy
Class IIa (Level of Evidence: B)
Recommendations for diagnosis of ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy
Class I (Level of Evidence: B)
Recommendations for diagnosis of ventricular arrhythmias in hypertrophic cardiomyopathy
Class I (Level of Evidence: B)

2017AHA/ACC/HRS Guideline for management of sudden cardiac arrest and ventricular arrhythmia

[3]

Class IIa (Level of Evidence: C)

References

  1. ↑ Zareba, Wojciech; Zareba, Karolina M. (2017). "Cardiac Magnetic Resonance in Sudden Cardiac Arrest Survivors". Circulation: Cardiovascular Imaging. 10 (12). doi:10.1161/CIRCIMAGING.117.007290. ISSN 1941-9651.
  2. ↑ Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA; et al. (2022). "2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death". Eur Heart J. 43 (40): 3997–4126. doi:10.1093/eurheartj/ehac262. PMID 36017572 Check |pmid= value (help).
  3. ↑ Al-Khatib, Sana M.; Stevenson, William G.; Ackerman, Michael J.; Bryant, William J.; Callans, David J.; Curtis, Anne B.; Deal, Barbara J.; Dickfeld, Timm; Field, Michael E.; Fonarow, Gregg C.; Gillis, Anne M.; Granger, Christopher B.; Hammill, Stephen C.; Hlatky, Mark A.; Joglar, José A.; Kay, G. Neal; Matlock, Daniel D.; Myerburg, Robert J.; Page, Richard L. (2018). "2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death". Circulation. 138 (13). doi:10.1161/CIR.0000000000000549. ISSN 0009-7322.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Sudden_cardiac_death_MRI&oldid=1734952"